Abbvie Header week 48

Abbvie Header week 48

X

Company profile for Algernon Pharmaceuticals

Algernon Pharmaceuticals

ALGERNON PHARMACEUTICALS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

105 News

105 News

DEVELOPMENTS

71 Drug(s) in Development

71 Drug(s) in Development

Contact Supplier

Contact Supplier

Related Companies

Related Companies

Algernon Pharmaceuticals is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). The Algernon drug development program was the brainchild of Dr. Mark Williams, the Company’s CSO, whose innovative approach to drug discovery was developed over many years as senior scientis...

Algernon Pharmaceuticals is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). The Algernon drug development program was the brainchild of Dr. Mark Williams, the Company’s CSO, whose innovative approach to drug discovery was developed over many years as senior scientist in the drug development industry. The company and its business model is highly capital efficient and strives to deliver maximum shareholder value.

Sponsored Ad

pfizer-centreone-m-2022-12-05

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

pfizer-centreone-m-2022-12-05

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search